To this end we first investigated immunohistochemically the expression of Gli1 protein in normal ovarian surface epithelium and in advanced serous ovarian cancers and correlated its expression with clinicopathological parameters and patient outcomes. The gene discussed is GLI1; the disease is ovarian serous adenocarcinoma.